Abstract
Campylobacter fetus causes systemic infections in immunocompromised hosts. We describe a case in which C. fetus bacteremia apparently relapsed after 7 years in a patient with hypogammaglobulinemia and characterize the serum resistance of the patient's C. fetus strain and the inability of the patient's serum, with and without commercial intravenous immunoglobulin, to opsonize this and another C. fetus strain effectively. The probable presence of a sequestered site of infection in bone, the intrinsic serum resistance of the C. fetus strain, and the absence of specific antibody may account for the persistent infection in this patient. These studies suggest that intravenous immunoglobulin treatment is not useful in eradicating C. fetus bacteremia.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blaser M. J., Pei Z. Pathogenesis of Campylobacter fetus infections: critical role of high-molecular-weight S-layer proteins in virulence. J Infect Dis. 1993 Feb;167(2):372–377. doi: 10.1093/infdis/167.2.372. [DOI] [PubMed] [Google Scholar]
- Blaser M. J., Smith P. F., Hopkins J. A., Heinzer I., Bryner J. H., Wang W. L. Pathogenesis of Campylobacter fetus infections: serum resistance associated with high-molecular-weight surface proteins. J Infect Dis. 1987 Apr;155(4):696–706. doi: 10.1093/infdis/155.4.696. [DOI] [PubMed] [Google Scholar]
- Blaser M. J., Smith P. F., Repine J. E., Joiner K. A. Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance. J Clin Invest. 1988 May;81(5):1434–1444. doi: 10.1172/JCI113474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Francioli P., Herzstein J., Grob J. P., Vallotton J. J., Mombelli G., Glauser M. P. Campylobacter fetus subspecies fetus bacteremia. Arch Intern Med. 1985 Feb;145(2):289–292. [PubMed] [Google Scholar]
- Fujimoto S., Takade A., Amako K., Blaser M. J. Correlation between molecular size of the surface array protein and morphology and antigenicity of the Campylobacter fetus S layer. Infect Immun. 1991 Jun;59(6):2017–2022. doi: 10.1128/iai.59.6.2017-2022.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guerrant R. L., Lahita R. G., Winn W. C., Jr, Roberts R. B. Campylobacteriosis in man: pathogenic mechanisms and review of 91 bloodstream infections. Am J Med. 1978 Oct;65(4):584–592. doi: 10.1016/0002-9343(78)90845-8. [DOI] [PubMed] [Google Scholar]
- KILO C., HAGEMANN P. O., MARZI J. SEPTIC ARTHRITIS AND BACTEREMIA DUE TO VIBRIO FETUS: REPORT OF AN UNUSUAL CASE AND REVIEW OF THE LITERATURE. Am J Med. 1965 Jun;38:962–971. doi: 10.1016/0002-9343(65)90017-3. [DOI] [PubMed] [Google Scholar]
- Kerstens P. J., Endtz H. P., Meis J. F., Oyen W. J., Koopman R. J., van den Broek P. J., van der Meer J. W. Erysipelas-like skin lesions associated with Campylobacter jejuni septicemia in patients with hypogammaglobulinemia. Eur J Clin Microbiol Infect Dis. 1992 Sep;11(9):842–847. doi: 10.1007/BF01960888. [DOI] [PubMed] [Google Scholar]
- Lawrence R., Nibbe A. F., Levin S. Lung abscess secondary to vibrio fetus, malabsorption syndrome and acquired agammaglobulinemia. Chest. 1971 Aug;60(2):191–194. doi: 10.1378/chest.60.2.191. [DOI] [PubMed] [Google Scholar]
- Pei Z., Blaser M. J. Pathogenesis of Campylobacter fetus infections. Role of surface array proteins in virulence in a mouse model. J Clin Invest. 1990 Apr;85(4):1036–1043. doi: 10.1172/JCI114533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schmidt U., Chmel H., Kaminski Z., Sen P. The clinical spectrum of Campylobacter fetus infections: report of five cases and review of the literature. Q J Med. 1980 Autumn;49(196):431–442. [PubMed] [Google Scholar]